Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Do Not Access QA-Reviewed Records Without Proper Authorization

Posted on June 3, 2025 By digi

Do Not Access QA-Reviewed Records Without Proper Authorization

Unauthorized Access to QA-Reviewed Records Is Prohibited in GMP

Remember: Once GMP documents are QA-reviewed and archived, they must be accessed only by authorized personnel to protect data integrity.

Why This Matters in GMP

QA-reviewed records—such as batch manufacturing records (BMRs), deviation reports, or analytical logs—are official GMP documents used to verify product release, audit trails, and compliance evidence. Allowing unauthorized personnel to access or modify these documents undermines data integrity, audit readiness, and traceability. GMP guidelines require that once reviewed and approved, documents be secured from tampering or accidental modification. This principle applies equally to paper and electronic systems. Any unauthorized changes, deletions, or data exports without QA approval violate core GMP standards and compromise product legality and safety.

Also Read:  Label In-Process Samples with Date and Initials for Traceability

Regulatory and Compliance Implications

FDA 21 CFR Part 211.180 and 211.186 require controlled access to official records and retention of their integrity. EU GMP Chapter 4 and WHO GMP stress strict document control, including version management and access logs. Schedule M mandates QA oversight on all finalized GMP documentation. Auditors inspect record access logs, electronic system controls, and paper storage areas. Uncontrolled access is treated as a critical observation and may be flagged as a data integrity violation. Only designated QA personnel or approved roles should retrieve, review, or finalized records.

Implementation Best Practices

  • Restrict access to archived GMP records through secure cabinets or electronic access controls.
  • Define user roles in document systems—view-only vs. permissions with audit trails.
  • Maintain access logs and review them periodically to detect any unauthorized activity.
  • Train personnel on documentation security protocols and consequences of non-compliance.
  • Include a document request process where QA reviews and approves any file retrievals.
Also Read:  Schedule M (Revised) GMP Guidelines for API Manufacturing in India

Regulatory References

  • FDA 21 CFR Part 211.180 – Record Retention and Access
  • FDA 21 CFR Part 211.186 – Master Production and Control Records
  • EU GMP Chapter 4 – Documentation
  • WHO GMP – Document Control and Record Management
  • Schedule M – QA Document Security and Access Policies
GMP Tips Tags:audit readiness, data integrity, document control, document traceability, electronic document systems, EU GMP Chapter 4, FDA 21 CFR Part 211, GMP compliance, QA authorization, quality oversight, record access, record security, Schedule M, WHO GMP

Post navigation

Previous Post: Common GMP Violations Noted in FDA 483s
Next Post: Role of FDA’s Office of Regulatory Affairs (ORA)

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Store Samples with Adequate Overage for Retesting and Stability Studies

    Store Samples with Adequate Overage… Read more

GMP Tips

  • Store Samples with Adequate Overage for Retesting and Stability Studies
  • Do Not Access QA-Reviewed Records Without Proper Authorization
  • Maintain Clear Segregation Between Different Product Families in GMP
  • Never Place Open Materials Near HVAC Exhausts in GMP Zones
  • Conduct Media Fills to Validate Aseptic Process Integrity in GMP
  • Never Use Handwritten Labels on Released GMP Goods
  • Install Insect Traps in Non-Sterile GMP Manufacturing Areas
  • Never Apply Pressure to HEPA Filters During Cleaning in GMP Facilities
  • Document Operator Training for Each Product Line to Ensure GMP Compliance
  • Never Sign Blank Fields in Controlled GMP Documents

More about GMP Tips :

  • Do Not Ignore Elevated Noise Levels in GMP Classified Areas
  • Validate Software Used in GMP Data Acquisition Systems
  • Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination
  • Cross-Verify Certificate of Analysis (COA) With Raw Data for GMP Assurance
  • Maintain Temperature Logs for Cold Chain Pharmaceutical Products
  • Never Conduct Sampling Without Wearing Clean Area Garments
  • Do Not Store Chemicals Without Material Safety Data Sheets (MSDS)
  • Never Use Trial Batches for Commercial Release Under GMP
  • Maintain Access Logs for Electronic GMP Systems to Ensure Accountability
  • Validate Cleaning Procedures for Both Dedicated and Shared Equipment
  • Never Use Photocopies as Originals for GMP Quality Documents
  • Never Place Open Materials Near HVAC Exhausts in GMP Zones
  • Assign Identification Numbers to All Cleaning Tools for Traceability
  • Never Mix Product Labels from Different Batches in the Packaging Area
  • Do Not Allow Incomplete Documentation During GMP Batch Record Review

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme